Relationship of HIV-1 and SIV envelope glycoprotein trimer occupation and neutralization

被引:39
作者
Crooks, Emma T. [1 ]
Jiang, Pengfei [1 ]
Franti, Michael [2 ]
Wong, Sharon [1 ]
Zwick, Michael B. [3 ]
Hoxie, James A. [4 ]
Robinson, James E. [5 ]
Moore, Penny L. [6 ]
Binley, James M. [1 ]
机构
[1] Torrey Pines Inst Mol Studies, San Diego, CA 92121 USA
[2] Novartis Inst Biomed Res, Cambridge, MA 02139 USA
[3] Scripps Res Inst, La Jolla, CA 92037 USA
[4] Univ Penn, Philadelphia, PA 19104 USA
[5] Tulane Univ, Med Ctr, New Orleans, LA 70112 USA
[6] Natl Inst Communicable Dis, ZA-2131 Johannesburg, South Africa
关键词
HIV-1; SIV; envelope; glycoprotein; gp120; gp41; antibody; neutralization; stoichiometry; occupancy;
D O I
10.1016/j.virol.2008.04.045
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Insights into the process of HIV-1 neutralization may assist rational vaccine design. Here, we compared antibody neutralization against the JR-FL primary isolate and trimer binding affinities judged by native PAGE. Monovalent Fab-trimer binding and neutralization showed a direct quantitative relationship, implying that neutralization begins as each trimer is occupied by one antibody. At saturation, three Fab or soluble CD4 molecules engaged each trimer. In contrast, a maximum of one soluble CD4 molecule bound to functional SIV trimers with a truncated a gp41 tail. Remarkably, soluble CD4 was found to trigger dramatic enhancement of this virus. Unlike Fabs, a quantitative correlation between JR-FL trimer binding and neutralization was unclear for some, but not all IgGs, as neutralization was markedly increased, but trimer affinity was largely unchanged. In addition, only one molecule of certain gp41-specific IgGs appeared to be able to bind each trimer. We discuss the implications of these findings in weighing the relative contributions of size, multivalent binding and other possible effects of IgGs to explain their increased potency. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:364 / 378
页数:15
相关论文
共 92 条
[1]   Biochemical and biological characterization of a dodecameric CD4-Ig fusion protein - Implications for therapeutic and vaccine strategies [J].
Arthos, J ;
Cicala, C ;
Steenbeke, TD ;
Chun, TW ;
Cruz, CD ;
Hanback, DB ;
Khazanie, P ;
Nam, D ;
Schuck, P ;
Selig, SM ;
Van Ryk, D ;
Chaikin, MA ;
Fauci, AS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (13) :11456-11464
[2]   MOLECULAR PROFILE OF AN ANTIBODY-RESPONSE TO HIV-1 AS PROBED BY COMBINATORIAL LIBRARIES [J].
BARBAS, CF ;
COLLET, TA ;
AMBERG, W ;
ROBEN, P ;
BINLEY, JM ;
HOEKSTRA, D ;
CABABA, D ;
JONES, TM ;
WILLIAMSON, RA ;
PILKINGTON, GR ;
HAIGWOOD, NL ;
CABEZAS, E ;
SATTERTHWAIT, AC ;
SANZ, I ;
BURTON, DR .
JOURNAL OF MOLECULAR BIOLOGY, 1993, 230 (03) :812-823
[3]   Cryoelectron tomographic analysis of an HIV-neutralizing protein and its complex with native viral gp120 [J].
Bennett, Adam ;
Liu, Jun ;
Van Ryk, Donald ;
Bliss, Donald ;
Arthos, James ;
Henderson, Robert M. ;
Subramaniam, Sriram .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (38) :27754-27759
[4]   Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies [J].
Binley, JA ;
Wrin, T ;
Korber, B ;
Zwick, MB ;
Wang, M ;
Chappey, C ;
Stiegler, G ;
Kunert, R ;
Zolla-Pazner, S ;
Katinger, H ;
Petropoulos, CJ ;
Burton, DR .
JOURNAL OF VIROLOGY, 2004, 78 (23) :13232-13252
[5]   Inhibition of HIV Env binding to cellular receptors by monoclonal antibody 2GI2 as probed by Fc-tagged gp120 [J].
Binley, James M. ;
Ngo-Abdalla, Stacie ;
Moore, Penny ;
Bobardt, Michael ;
Chatterji, Udayan ;
Gallay, Philippe ;
Burton, Dennis R. ;
Wilson, Ian A. ;
Elder, John H. ;
de Parseval, Aymeric .
RETROVIROLOGY, 2006, 3 (1)
[6]   Human antibody responses to HIV type 1 glycoprotein 41 cloned in phage display libraries suggest three major epitopes are recognized and give evidence for conserved antibody motifs in antigen binding [J].
Binley, JM ;
Ditzel, HJ ;
Barbas, CF ;
Sullivan, N ;
Sodroski, J ;
Parren, PWHI ;
Burton, DR .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1996, 12 (10) :911-924
[7]   Redox-triggered infection by disulfide-shackled human immunodeficiency virus type 1 pseudovirions [J].
Binley, JM ;
Cayanan, CS ;
Wiley, C ;
Schülke, N ;
Olson, WC ;
Burton, DR .
JOURNAL OF VIROLOGY, 2003, 77 (10) :5678-5684
[8]   A single amino acid change and truncated TM are sufficient for simian immunodeficiency virus to enter cells using CCR5 in a CD4-independent pathway [J].
Bonavia, A ;
Bullock, BT ;
Gisselman, KM ;
Margulies, BJ ;
Clements, JE .
VIROLOGY, 2005, 341 (01) :12-23
[9]   CRYPTIC NATURE OF ENVELOPE V3 REGION EPITOPES PROTECTS PRIMARY MONOCYTOTROPIC HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 FROM ANTIBODY NEUTRALIZATION [J].
BOUHABIB, DC ;
RODERIQUEZ, G ;
ORAVECZ, T ;
BERMAN, PW ;
LUSSO, P ;
NORCROSS, MA .
JOURNAL OF VIROLOGY, 1994, 68 (09) :6006-6013
[10]   Biologic and genetic characterization of a panel of 60 human immunodeficiency virus type 1 isolates, representing clades A, B, C, D, CRF01_AE, and CRF02_AG, for the development and assessment of candidate vaccines [J].
Brown, BK ;
Darden, JM ;
Tovanabutra, S ;
Oblander, T ;
Frost, J ;
Sanders-Buell, E ;
de Souza, MS ;
Birx, DL ;
McCutchan, FE ;
Polonis, VR .
JOURNAL OF VIROLOGY, 2005, 79 (10) :6089-6101